BACKGROUND: Physicians identify from 45.7 to 96.2 % of Adverse Drug Reactions (ADRs) in their patients, with under-reporting ranging from 6 to 100 %. In order to improve ADR reporting, several interventions have been evaluated in different studies, but not with regard to ADR identification. In addition, it is not known whether some patient characteristics might influence on ADR identification and reporting by physicians. OBJECTIVES: (a) To assess the effectiveness of a comprehensive intervention directed to Emergency Department physicians and coordinated by a pharmacist in a tertiary care pediatric hospital on ADR identification and reporting. (b) To assess if some of the children’s characteristics might influence on ADR identification and reporting. Setting The Emergency Department of the Hospital Infantil de México “Federico Gómez”, which is a national pediatric institute of health in México. METHODS: A Quasi-experimental, pre-post test trial was designed. During the intervention, the pharmacist gave talks on Pharmacovigilance and on the program for electronic capture of data, took part in patient visits, left reminders, improved accessibility to ADR report format and performed feedback activities. To classify and quantify correctly identified ADRs and ADRs reported to the Institutional Pharmacovigilance Center (IPC), 1136 clinical records were reviewed. The models were adjusted for patient variables. MAIN OUTCOME MEASURES: Total ADRs, ADRs correctly identified by physicians, ADRs reported to the IPC by physicians. Results Before the intervention, 97 % of ADRs were correctly identified and 6.1 % reported by physicians. During the intervention, 99.6 % were correctly identified and 41.2 % were reported, and after the intervention, 99.6 and 41.7 %, respectively. Identification during the intervention showed a sevenfold increase with regard to preintervention and was maintained post-intervention. ADR reporting during the intervention showed a 14-fold increase with regard to pre-intervention and was maintained during post-intervention. CONCLUSION: Physicians do identify ADRs, but fail to report them. The intervention increased ADR correct identification and reporting. The effect was maintained after the intervention.
BACKGROUND: Physicians identify from 45.7 to 96.2 % of Adverse Drug Reactions (ADRs) in their patients, with under-reporting ranging from 6 to 100 %. In order to improve ADR reporting, several interventions have been evaluated in different studies, but not with regard to ADR identification. In addition, it is not known whether some patient characteristics might influence on ADR identification and reporting by physicians. OBJECTIVES: (a) To assess the effectiveness of a comprehensive intervention directed to Emergency Department physicians and coordinated by a pharmacist in a tertiary care pediatric hospital on ADR identification and reporting. (b) To assess if some of the children’s characteristics might influence on ADR identification and reporting. Setting The Emergency Department of the Hospital Infantil de México “Federico Gómez”, which is a national pediatric institute of health in México. METHODS: A Quasi-experimental, pre-post test trial was designed. During the intervention, the pharmacist gave talks on Pharmacovigilance and on the program for electronic capture of data, took part in patient visits, left reminders, improved accessibility to ADR report format and performed feedback activities. To classify and quantify correctly identified ADRs and ADRs reported to the Institutional Pharmacovigilance Center (IPC), 1136 clinical records were reviewed. The models were adjusted for patient variables. MAIN OUTCOME MEASURES: Total ADRs, ADRs correctly identified by physicians, ADRs reported to the IPC by physicians. Results Before the intervention, 97 % of ADRs were correctly identified and 6.1 % reported by physicians. During the intervention, 99.6 % were correctly identified and 41.2 % were reported, and after the intervention, 99.6 and 41.7 %, respectively. Identification during the intervention showed a sevenfold increase with regard to preintervention and was maintained post-intervention. ADR reporting during the intervention showed a 14-fold increase with regard to pre-intervention and was maintained during post-intervention. CONCLUSION: Physicians do identify ADRs, but fail to report them. The intervention increased ADR correct identification and reporting. The effect was maintained after the intervention.
Authors: Karen E Lasser; Paul D Allen; Steffie J Woolhandler; David U Himmelstein; Sidney M Wolfe; David H Bor Journal: JAMA Date: 2002-05-01 Impact factor: 56.272
Authors: Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert Journal: Eur J Clin Pharmacol Date: 2011-12-14 Impact factor: 2.953
Authors: Shobha Phansalkar; Jennifer M Hoffman; Jonathan R Nebeker; John F Hurdle Journal: Am J Health Syst Pharm Date: 2007-04-15 Impact factor: 2.637
Authors: Alan J Forster; Alison Jennings; Claire Chow; Ciera Leeder; Carl van Walraven Journal: J Am Med Inform Assoc Date: 2012 Jan-Feb Impact factor: 4.497
Authors: K J Meador; G A Baker; N Browning; J Clayton-Smith; D T Combs-Cantrell; M Cohen; L A Kalayjian; A Kanner; J D Liporace; P B Pennell; M Privitera; D W Loring Journal: Neurology Date: 2010-11-24 Impact factor: 9.910
Authors: Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring Journal: Lancet Neurol Date: 2013-01-23 Impact factor: 44.182
Authors: Ruairi M Gallagher; Jennifer R Mason; Kim A Bird; Jamie J Kirkham; Matthew Peak; Paula R Williamson; Anthony J Nunn; Mark A Turner; Munir Pirmohamed; Rosalind L Smyth Journal: PLoS One Date: 2012-12-04 Impact factor: 3.240
Authors: Olga Morales-Ríos; Luis Jasso-Gutiérrez; Alfonso Reyes-López; Juan Garduño-Espinosa; Onofre Muñoz-Hernández Journal: PLoS One Date: 2018-01-05 Impact factor: 3.240
Authors: Ar Kar Aung; Steven Walker; Yin Li Khu; Mei Jie Tang; Jennifer I Lee; Linda Velta Graudins Journal: Eur J Clin Pharmacol Date: 2022-02-16 Impact factor: 2.953
Authors: Olga Morales-Ríos; Carlo Cicero-Oneto; Carlos García-Ruiz; Dina Villanueva-García; Maribelle Hernández-Hernández; Víctor Olivar-López; Rodolfo Norberto Jiménez-Juárez; Luis Jasso-Gutiérrez Journal: PLoS One Date: 2020-03-24 Impact factor: 3.240